Annual report pursuant to Section 13 and 15(d)

DEFERRED COMPENSATION

v3.22.4
DEFERRED COMPENSATION
12 Months Ended
Dec. 31, 2022
DEFERRED COMPENSATION  
DEFERRED COMPENSATION

8.DEFERRED COMPENSATION

The Company deferred cash payment of management compensation for the Executive Chairman and Chief Executive Officer, Chief Scientific Officer, Chief Medical Officer and Chief Development Officer at December 31, 2020, in the amount of $1,398,989, which was repaid in full during the year ended December 31, 2021. As of December 31, 2021, all deferred compensation was paid in full.